The Commission is now operating in accordance with the Caretaker Conventions pending the outcome of the 2025 federal election.

High risk medicines

High risk medicines (HRMs) are medications that have an increased risk of causing significant patient harm or death if they are misused or used in error.1

Print

Updated eLearning Module

The Introduction to High Risk Medicines eLearning Module has been revised and updated to help junior doctors, nurses and pharmacists learn more about the safe use of high risk medicines. 

The module can be accessed by account holders on HRM Education website.

Overview

HRMs include:

  • Medicines with a narrow therapeutic index
  • Medicines that present a high risk when
    • Administered via the wrong route or
    • Other medication management system errors occur.

Errors with these medicines are not necessarily more common than with other medicines. As they have a very narrow margin of safety, the consequences of errors with these medicines can be more devastating.2

There is no standard list of high risk medicines in Australia. Lists of HRMs have been created largely based on incident reporting systems in different health services, jurisdictions and countries. In the USA and Canada, HRMs are known as ‘high-alert medications’.2

High risk medicines may vary between hospitals and other health care settings depending on the types of medicines used and patients treated. In the acute sector in Australia, the ‘APINCH’ acronym and classification is widely used to assist clinicians focus on a group of medicines known to be associated with high potential for medication-related harm.3

The ‘APINCH’ classification is not an exhaustive list.

Other medicines or classes of medicines may also present a high risk. Examples include neuromuscular blocking agents, digoxin, antipsychotics and oral hypoglycaemics.

This section includes information and resources about:

HRM eLearning modules

The HRM eLearning modules are available to support healthcare professionals, particularly those working in settings where high risk medicines are used. These modules have been developed in collaboration with the Women's and Children's Health Network, South Australia.

To determine if your workplace email domain enables access to the eLearning modules, see the approved list of Health Service Organisation (HSO) email domains. Alternatively, individuals may register with any email domain and purchase access to the modules.

If you are a HSO and would like to arrange organisational access to the eLearning modules, please contact the HRM Helpdesk.

Further information, FAQs and technical support are available on the HRM Education site. We welcome the use of feedback tabs throughout the eLearning modules as part of our commitment to continuous improvement of their content. For more urgent issues, please contact the HRM helpdesk.

Access HRM eLearning

References

  1. Cohen MR. Medication Errors, 2nd edition. Washington DC. American Pharmacists Association; 2007.
  2. Institute for Safe Medication Practices (ISMP) (US). ISMP List of High-Alert Medications in Acute Care Settings. 2014. https://www.ismp.org/recommendations/high-alert-medications-acute-list (accessed September 2017).
  3. Clinical Excellence Commission (CEC). High-Risk Medicines A PINCH. http://www.cec.health.nsw.gov.au/patient-safety-programs/medication-safety/high-risk-medicines/A-PINCH (accessed September 2017).
Back to top